2013
DOI: 10.3390/ijms140714105
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol Inhibits Ionising Irradiation-Induced Inflammation in MSCs by Activating SIRT1 and Limiting NLRP-3 Inflammasome Activation

Abstract: IL-1β, a pro-inflammatory cytokine, has been shown to contribute to radiation injury. Sirt1, an NAD+-dependent class III protein deacetylase, plays an important role in the regulation of the proinflammatory cytokines involved in inflammation-associated diseases. The relationship between Sirt1 and IL-1β, however, has remained elusive. The present study was designed to explore the potential effect of Sirt1 on IL-1β expression induced by radiation and to provide a new target for the development of radiation prote… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
70
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 115 publications
(78 citation statements)
references
References 34 publications
4
70
0
Order By: Relevance
“…IL-1β is synthesized as an inactive precursor (pro-IL-1β) that is cleaved by caspase-1 following formation of the inflammasome consequent to tissue injury, as following XRT (11)(12)(13)27,28). The activation of the inflammasome pathway may be due to the production of reactive oxygen species after exposure to ionizing radiation or to the production or release of damage-associated molecular patterns by irradiated cells (27)(28)(29)(30)). Activation of the inflammasome then leads to IL-1β processing and release, and inflammatory cell death, leading to amplification of the inflammatory response and injury (31).…”
Section: Discussionmentioning
confidence: 99%
“…IL-1β is synthesized as an inactive precursor (pro-IL-1β) that is cleaved by caspase-1 following formation of the inflammasome consequent to tissue injury, as following XRT (11)(12)(13)27,28). The activation of the inflammasome pathway may be due to the production of reactive oxygen species after exposure to ionizing radiation or to the production or release of damage-associated molecular patterns by irradiated cells (27)(28)(29)(30)). Activation of the inflammasome then leads to IL-1β processing and release, and inflammatory cell death, leading to amplification of the inflammatory response and injury (31).…”
Section: Discussionmentioning
confidence: 99%
“…As a SIRT1 activator [42,43] , resveratrol was used to identify whether acetylated STAT3 is involved in the activation of STAT3 signaling. The basal STAT3 acetylation on Lys685 was decreased by resveratrol, resulting in negation of Ang II-induced upregulation www.chinaphar.com Ni J et al Acta Pharmacologica Sinica npg of STAT3 Try705 phosphorylation and the downstream profibrotic genes.…”
Section: Discussionmentioning
confidence: 99%
“…Resveratrol, an activator of SIRT1 [42,43] , reduced the basal STAT3 acetylation on Lys685 ( Figure 3A). Resveratrol pretreatment of tubular epithelial cells prevented Ang II-induced upregulation of STAT3 phosphorylation on Tyr705 ( Figure 3A).…”
Section: Resveratrol Prevented Ang Ii-induced Stat3 Phosphorylation Omentioning
confidence: 99%
See 1 more Smart Citation
“…Agents that can be radioprotective must counter some or all the damaging effects of radiological exposure in the cell including those mentioned above. Radiation-induced inflammation, an important side effect that contributes to normal tissue injury, has been reported in many species (Linard et al, 2004;Fliedner et al, 2005;Kong et al, 2005;Fleckenstein et al, 2007;Haston et al, 2007;Rodemann and Blaese, 2007;Hill et al, 2011;Multhoff and Radons, 2012;Rastogi et al, 2012;Cho et al, 2013;Fu et al, 2013;Jiang et al, 2013;McCurdy et al, 2013;Moore et al, 2013;Mukherjee et al, 2014). The initial phase of radiationinduced injury is marked by the increase in the synthesis of pro-inflammatory cytokines such as transforming growth factor-beta1 (TGF-β1), tumor necrosis factor-alpha (TNF-α) and several other members of interleukin (IL) family (Linard et al, 2004;Fliedner et al, 2005;Kong et al, 2005;Mehta, 2005;Fleckenstein et al, 2007;Haston et al, 2007;Rodemann and Blaese 2007;Jindal et al, 2009;Hei et al, 2011;Janko et al, 2012;Monceau et al, 2013).…”
Section: Lakhan Kmamentioning
confidence: 99%